TRCT
DRTSW icon

Tower Research Capital (TRC)’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Tower Research Capital (TRC)’s Portfolio DRTSW Stock Details DRTSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-358
Closed -$75 – 5315
2024
Q4 		$75 Hold
358
– – ﹤0.01% 5504
2024
Q3 		$70 Hold
358
– – ﹤0.01% 5548
2024
Q2 		$85 Hold
358
– – ﹤0.01% 5503
2024
Q1 		$90 Hold
358
– – ﹤0.01% 5667
2023
Q4 		$69 Hold
358
– – ﹤0.01% 5747
2023
Q3 		$95 Hold
358
– – ﹤0.01% 5733
2023
Q2 		$141 Hold
358
– – ﹤0.01% 5780
2023
Q1 		$0 Hold
358
– – ﹤0.01% 5897
2022
Q4 		$0 Hold
358
– – ﹤0.01% 5973
2022
Q3 		$0 Hold
358
– – ﹤0.01% 6139
2022
Q2 		$0 Hold
358
– – ﹤0.01% 6155
2022
Q1 		$0 Buy
+358
New +$195 ﹤0.01% 6164

Other funds holding DRTSW

MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
VB
Value Base Tel Aviv, Israel $127M AUM 12.37% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Tower Research Capital (TRC)'s DRTSW Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of Alpha Tau Medical Warrant (DRTSW) in Q1 2025, closing a stake of 358 shares — an estimated $75 sold.

Tower Research Capital (TRC) first reported a position in DRTSW in Q1 2022 and held it in 12 quarters. The position peaked at $141 in Q2 2023. 23 funds tracked by Wall St. Rank hold DRTSW as of Q1 2025.

  • Tower Research Capital (TRC) reported no remaining Alpha Tau Medical Warrant position as of Q1 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 358 Alpha Tau Medical Warrant shares in Q1 2025, an estimated $75.
  • Tower Research Capital (TRC) first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 12 quarters.
  • Tower Research Capital (TRC)'s Alpha Tau Medical Warrant position peaked at $141 in Q2 2023.
  • 23 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.